PERSPECTA

News from every angle

← Back to headlines

Pfizer and BioNTech Halt US COVID-19 Vaccine Study

Pfizer and BioNTech have halted a U.S. COVID-19 vaccine study, citing difficulties in recruitment and weak demand for the shots.

2 Apr, 01:53 — 2 Apr, 01:53
PostShare

Sources

Showing 1 of 1 sources
japan-timesMostly Factual147d ago

Pfizer and BioNTech halt U.S. COVID-19 vaccine study after recruitment struggles

The move comes as COVID vaccine ‌makers grapple ‌with pushback from the U.S. administration and weak U.S. demand for the shots.

Read full article →

Related Stories

U.S. FDA Approves Landmark Pancreatic Cancer Drug With Improved Survival Rates

39m ago

Australian Woman Gives Birth to Twins Fathered by Two Different Men

50m ago

North Macedonia Reports New West Nile Virus Fatality Amid Enhanced Surveillance

1h ago

Germany Reports Record 15,800 Heat-Related Deaths This Summer

2h ago